Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: A cross sectional study

Respiratory Research

Volumn 9, Issue , 2008, Pages

  Ulrich, Silvia ^a,b   Taraseviciene Stewart, Laima ^b   Huber, Lars C ^a   Speich, Rudolf ^a   Voelkel, Norbert ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MIDDLE AGED; PROTEIN MICROARRAY; PROTEOMICS; PULMONARY HYPERTENSION; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; UPREGULATION;

ADULT; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; PROTEOMICS; REFERENCE VALUES; RNA; SENSITIVITY AND SPECIFICITY; UP-REGULATION;

EID: 40949147029     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-9-20     Document Type: Article

References (31)

1. Voelkel NF, Cool C. Pathology of pulmonary hypertension. Cardiol Clin 2004, 22(3):343-351. 10.1016/j.ccl.2004.04.010, 15302355.
2. Voelkel NF, Cool C, Lee SD, Wright L, Geraci MW, Tuder RM. Primary pulmonary hypertension between inflammation and cancer. Chest 1998, 114(3 Suppl):225S-230S. 10.1378/chest.114.3_Supplement.225S, 9741573.
3. Dorfmuller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003, 22(2):358-363. 10.1183/09031936.03.00038903, 12952274.
4. Yanai-Landau H, Amital H, Bar-Dayan Y, Levy Y, Gur H, Lin HC, Alosachie IJ, Peter JB, Shoenfeld Y. Autoimmune aspects of primary pulmonary hypertension. Pathobiology 1995, 63(2):71-75.
5. Tamby MC, Chanseaud Y, Humbert M, Fermanian J, Guilpain P, Garcia-de-la-Pena-Lefebvre P, Brunet S, Servettaz A, Weill B, Simonneau G, Guillevin L, Boissier MC, Mouthon L. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 2005, 60(9):765-772. 10.1136/thx.2004.029082, 16135682.
6. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004, 43(12 Suppl S):5S-12S. 10.1016/j.jacc.2004.02.037, 15194173.
7. Geraci MW, Moore M, Gesell T, Yeager ME, Alger L, Golpon H, Gao B, Loyd JE, Tuder RM, Voelkel NF. Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res 2001, 88(6):555-562.
8. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996, 14(13):1675-1680. 10.1038/nbt1296-1675, 9634850.
9. Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science 1999, 285(5432):1390-1393. 10.1126/science.285.5432.1390, 10464095.
10. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286(5439):531-537. 10.1126/science.286.5439.531, 10521349.
11. Massague J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103(2):295-309. 10.1016/S0092-8674(00)00121-5, 11057902.
12. Bull TM, Coldren CD, Geraci MW, Voelkel NF. Gene expression profiling in pulmonary hypertension. Proc Am Thorac Soc 2007, 4(1):117-120. 10.1513/pats.200605-128JG, 17202300.
13. Tamby MC, Humbert M, Guilpain P, Servettaz A, Dupin N, Christner JJ, Simonneau G, Fermanian J, Weill B, Guillevin L, Mouthon L. Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension. Eur Respir J 2006, 28(4):799-807. 10.1183/09031936.06.00152705, 16774952.
14. Wiehler S, Proud D. Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 2007, 293(2):L505-15. 10.1152/ajplung.00066.2007, 17545490.
15. Donnarumma G, Paoletti I, Buommino E, Iovene MR, Tudisco L, Cozza V, Tufano MA. Anti-inflammatory effects of moxifloxacin and human beta-defensin 2 association in human lung epithelial cell line (A549) stimulated with lipopolysaccharide. Peptides 2007,
16. Ashitani J, Matsumoto N, Nakazato M. Elevated alpha-defensin levels in plasma of patients with pulmonary sarcoidosis. Respirology 2007, 12(3):339-345. 10.1111/j.1440-1843.2007.01061.x, 17539836.
17. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004, 43(12 Suppl S):13S-24S. 10.1016/j.jacc.2004.02.029, 15194174.
18. Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, Voelkel NF. Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J 2005, 26(6):1110-1118. 10.1183/09031936.05.00045705, 16319344.
19. Efferth T, Verdorfer I, Miyachi H, Sauerbrey A, Drexler HG, Chitambar CR, Haber M, Gebhart E. Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell lines. Blood Cells Mol Dis 2002, 29(1):1-13. 10.1006/bcmd.2002.0530, 12482398.
20. Calabretta B, Battini R, Kaczmarek L, de Riel JK, Baserga R. Molecular cloning of the cDNA for a growth factor-inducible gene with strong homology to S-100, a calcium-binding protein. J Biol Chem 1986, 261(27):12628-12632.
21. Lefranc F, Golzarian J, Chevalier C, DeWitte O, Pochet R, Heizman C, Decaestecker C, Brotchi J, Salmon I, Kiss R. Expression of members of the calcium-binding S-100 protein family in a rat model of cerebral basilar artery vasospasm. J Neurosurg 2002, 97(2):408-415.
22. Buchi S, Brandli O, Klingler K, Klaghofer R, Buddeberg C. [Inpatient rehabilitation in inpatients with chronic obstructive lung diseases (COPD): effect on physical capacity for work, psychological wellbeing and quality of life]. SchweizMedWochenschr 2000, 130(5):135-142. 10701230.
23. Prosser HM, Bradley A, Chesham JE, Ebling FJ, Hastings MH, Maywood ES. Prokineticin receptor 2 (Prokr2) is essential for the regulation of circadian behavior by the suprachiasmatic nuclei. Proc Natl Acad Sci U S A 2007, 104(2):648-653. 1761911, 17202262, 10.1073/pnas.0606884104.
24. Podlovni H, Ovadia O, Kisliouk T, Klipper E, Zhou QY, Friedman A, Alfaidy N, Meidan R. Differential expression of prokineticin receptors by endothelial cells derived from different vascular beds: a physiological basis for distinct endothelial function. Cell Physiol Biochem 2006, 18(6):315-326. 10.1159/000097609, 17170518.
25. Pasquali D, Rossi V, Staibano S, De Rosa G, Chieffi P, Prezioso D, Mirone V, Mascolo M, Tramontano D, Bellastella A, Sinisi AA. The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy. Endocrinology 2006, 147(9):4245-4251. 10.1210/en.2006-0614, 16763065.
26. Fujiwara S, Yamashita Y, Choi YL, Watanabe H, Kurashina K, Soda M, Enomoto M, Hatanaka H, Takada S, Ozawa K, Mano H. Transforming activity of purinergic receptor P2Y, G protein coupled, 8 revealed by retroviral expression screening. Leuk Lymphoma 2007, 48(5):978-986. 10.1080/10428190701225882, 17487742.
27. Hatanaka H, Takada S, Choi YL, Fujiwara S, Soda M, Enomoto M, Kurashina K, Watanabe H, Yamashita Y, Sugano K, Mano H. Transforming activity of purinergic receptor P2Y, G-protein coupled, 2 revealed by retroviral expression screening. Biochem Biophys Res Commun 2007, 356(3):723-726. 10.1016/j.bbrc.2007.03.048, 17382903.
28. Zee RY, Michaud SE, Diehl KA, Chasman DI, Emmerich J, Gaussem P, Aiach M, Ridker PM. Purinergic receptor P2Y, G-protein coupled, 12 gene variants and risk of incident ischemic stroke, myocardial infarction, and venous thromboembolism. Atherosclerosis 2007, 17707382.
29. Chen JX, Yan SD. Pathogenic role of mitochondral amyloid-beta peptide. Expert Rev Neurother 2007, 7(11):1517-1525. 10.1586/14737175.7.11.1517, 17997700.
30. Paris D, Quadros A, Patel N, DelleDonne A, Humphrey J, Mullan M. Inhibition of angiogenesis and tumor growth by beta and gamma-secretase inhibitors. Eur J Pharmacol 2005, 514(1):1-15. 10.1016/j.ejphar.2005.02.050, 15878319.
31. Fu C, Chute DJ, Farag ES, Garakian J, Cummings JL, Vinters HV. Comorbidity in dementia: an autopsy study. Arch Pathol Lab Med 2004, 128(1):32-38.